Drug Trial Radar · NCT03110562
Bortezomib, Selinexor, and Dexamethasone in Patients With Multiple Myeloma
Last checked: Nov 20, 2026Latest source record: Aug 21, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
402
Actual
Start
May 24, 2017
Primary completion
Feb 18, 2020
Study completion May 12, 2022
Sponsor
- Lead sponsor
- Karyopharm Therapeutics IncIndustry
- Sponsor type
- Industry
- First posted
- Apr 12, 2017
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This Phase 3, 2-arm, randomized, active comparator-controlled, open-label, multicenter study will compare the efficacy and health-related quality of life (HR-QoL) and assess the safety of selinexor plus bortezomib (Velcade) plus low-dose dexamethasone (SVd) versus bortezomib plus low-dose dexamethasone (Vd) in adult patients with RRMM who have received 1 to 3 prior anti-multiple myeloma (MM) regimens. Crossover from the Vd Arm to a treatment that includes selinexor (i.e., SVdX or SdX) will be allowed at the point of IRC-confirmed objective disease progression per the IMWG criteria for patients in the Vd Arm.
Conditions
- Multiple Myeloma
Interventions
SelinexorDrug
oral 100 mg dose
BortezomibDrug
subcutaneous dose of 1.3 mg/m2
DexamethasoneDrug
oral dose of 20mg
Primary outcomes
What the sponsor says the trial is designed to measure.
- SVd/Vd Arm: Progression-free Survival (PFS) as Assessed by Independent Review Committee (IRC)Time frame: From date of randomization until IRC-confirmed documented PD or death, censored date, whichever occurred first (up to 33 months)
Locations
157 sites in 21 countries. Site status is shown where the registry gives one.
Boca Raton Clinical Research (BRCR) Medical Center
Plantation, Florida
Emory University
Atlanta, Georgia
Kaiser Permanente Hawaii
Honolulu, Hawaii
McFarland Clinic
Ames, Iowa
Stormont Vail Health Care (Cotton O'Neil Cancer Center )
Topeka, Kansas
Commonwealth Hematology
Danville, Kentucky
Norton Cancer Institute
Louisville, Kentucky
University of Maryland
Baltimore, Maryland
Central Care Cancer Center
Bolivar, Missouri
The Valley Hospital Luckow Pavilion
Paramus, New Jersey
Mount Sinai
New York, New York
The Cancer Institute at St. Francis Hospital
Roslyn, New York
Novant-Forsyth Memorial Hospital
Winston-Salem, North Carolina
University of Cincinnati Health
Cincinnati, Ohio
Southwest Cancer Center of Oklahoma
Lawton, Oklahoma
Kaiser Permanente Northwest OR
Portland, Oregon
SCOR AnMed Health Cancer Center
Anderson, South Carolina
Prairie Lakes Healthcare
Watertown, South Dakota
Baylor Sammons Cancer Center
Dallas, Texas
University of Texas Southwestern
Dallas, Texas
Calvary Mater Newcastle
Waratah, New South Wales, Australia
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia
Mater Misericordiae Limited and Mater Medical Research
South Brisbane, Queensland, Australia
Gold Coast University Hospital
Southport, Queensland, Australia
Royal Adelaide Hospital
Adelaide, South Australia, Australia
Flinders Medical Centre
Bedford Park, South Australia, Australia
St. Vincent's Hospital Melbourne
Fitzroy, Victoria, Australia
The Alfred Hospital
Melbourne, Victoria, Australia
Medical University Innsbruck, Department of Internal Medicine V (Hematology and Oncology)
Innsbruck, Austria
University Hospital Krems, Department of Internal Medicine II
Krems, Austria
Medical University of Vienna
Vienna, Austria
General Hospital Hietzing
Vienna, Austria
Wilhelminen Hospital, Department of Internal Medicine I, Center for Oncology & Hematology
Vienna, Austria
Jules Bordet Institute
Brussels, Belgium
UCL Saint-Luc
Brussels, Belgium
University Hospital Ghent
Ghent, Belgium
General Hospital Delta
Roeselare, Belgium
St. Augustinus Hospital
Wilrijk, Belgium
University Multiprofile Hospital for Active Treatment, Sveti Georgi Clinic of Clinical Hematology
Plovdiv, Bulgaria
University Multiprofile Hospital for Active Treatment, Sveti Ivan Rilski Clinic of Hematology
Sofia, Bulgaria
Showing 40 of 157 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.